Glaxosmithkline Pharma net profit declines 29.65% in the June 2013 quarter

Sales decline 2.32% to Rs 636.86 crore

Net profit of Glaxosmithkline Pharma declined 29.65% to Rs 115.04 crore in the quarter ended June 2013 as against Rs 163.52 crore during the previous quarter ended June 2012. Sales declined 2.32% to Rs 636.86 crore in the quarter ended June 2013 as against Rs 651.96 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales636.86651.96 -2 OPM %19.1833.78 -PBDT159.01250.70 -37 PBT154.03246.40 -37 NP115.04163.52 -30

Powered by Capital Market - Live News